From: Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional management
TNM staging
All studied patients (n = 40)
No.
%
Stage I
21
52.5%
Stage II
8
20%
Stage III
6
15%
Stage IV
5
12.5%